What is HC Wainwright’s Forecast for SGMO Q1 Earnings?
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Sangamo Therapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.06) per share for the quarter. […]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Sangamo Therapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.06) per share for the quarter. […]
